SAGE - Sage Therapeutics, Inc.
8.68
-0.020 -0.230%
Share volume: 22,698,684
Last Updated: 07-30-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$8.70
-0.02
0.00%
Summary score
40%
Profitability
25%
Dept financing
28%
Liquidity
50%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-21.19%
Return on assets
-18.56%
Return on sales
0%
Return on invested capital
186.43%
Total debt ratio
11%
Debt ratio change over timeo
0%
Current Ratio
11.17%
Quick Ratio
0%
Cash Position Ratio
6.11%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-24.2%
Return on assets
-21.02%
Return on sales
0%
Return on invested capital
187.43%
Total debt ratio
12.46%
Debt ratio change over timeo
0%
Current Ratio
9.1%
Quick Ratio
0%
Cash Position Ratio
4.05%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-36.85%
Return on assets
-29.62%
Return on sales
0%
Return on invested capital
156.53%
Total debt ratio
20.32%
Debt ratio change over time
0%
Current Ratio
4.98%
Quick Ratio
0%
Cash Position Ratio
2.71%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SAGE | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -21.19% | 4.12% | 5.6% | 28.84% |
| Return on assets | -18.56% | 2.87% | 3.58% | 3.88% |
| Return on sales | 0% | 20.56% | 28.52% | 38.24% |
| Return on invested capital | 186.43% | 4.34% | 6.5% | 4.27% |
| Profitability | 25% | 36% | 47% | 76% |
| Total debt ratio | 11% | 63.22% | 51.03% | 91.42% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 17% | 14% | 25% |
| Current Ratio | 9.1% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 0% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 4.05% | 0.31% | 0.62% | 0.55% |
| Liquididy | 50% | 19% | 32% | 27% |
| Short-term ratios | SAGE | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -24.2% | 3.9% | 5.53% | 29.97% |
| Return on assets | -21.02% | 2.93% | 3.51% | 3.83% |
| Return on sales | 0% | 20.94% | 28.11% | 37.61% |
| Return on invested capital | 187.43% | 4.21% | 6.14% | 4.25% |
| Profitability | 25% | 37% | 47% | 76% |
| Total debt ratio | 12.46% | 64.39% | 51.75% | 91.67% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 18% | 14% | 25% |
| Current Ratio | 9.1% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 0% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 4.05% | 0.31% | 0.62% | 0.55% |
| Liquididy | 50% | 21% | 34% | 30% |